[Malignant mesothelioma of the pleura following radiotherapy of Hodgkin disease].
Second neoplasms following chemotherapy and radiotherapy for Hodgkin's disease have been extensively described, including acute myeloblastic leukemia, non Hodgkin's lymphomas and various solid tumors. We report malignant pleural mesothelioma occurring 17 years after mantle radiotherapy and MOPP chemotherapy for Hodgkin's disease. According to Cahan's criteria, this mesothelioma may be considered as treatment-related. Fourteen similar cases have been previously published. Post-radiation mesothelioma might be characterised by limited stage at diagnosis and might be surgically removed at presentation.
Falchero
L
L
Unité d'oncologie médicale, service de radiothérapie-oncologie, centre hospitalier Lyon-Sud, France.
Coiffier
B
B
Guibert
B
B
Souquet
P J
PJ
Isaac Pinet
S
S
Trillet-Lenoir
V
V
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy*; D006801:Humans; D008466:Mechlorethamine / Q000008:administration & dosage; D008654:Mesothelioma / Q000209:etiology* / Q000473:pathology / Q000601:surgery; D008875:Middle Aged; D009381:Neoplasms, Radiation-Induced / Q000209:etiology* / Q000473:pathology / Q000601:surgery; D010997:Pleural Neoplasms / Q000209:etiology* / Q000473:pathology / Q000601:surgery; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone